No Image

[Corrections] Correction to Lancet Oncol 2019; 20: 1556–65

August 1, 2020 0

Summary: Bertelsen CA, Neuenschwander AU, Jansen JE, et al. 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study. Lancet Oncol 2019; 20: 1556–65—In this Article, two patients (one in the control group and one in the complete mesocolic excision group) were incorrectly classified as not […]

No Image

[Corrections] Correction to Lancet Oncol 2019; 20: 1474–76

August 1, 2020 0

Summary: West NP. Complete mesocolic excision for colon cancer: is now the time for a change in practice? Lancet Oncol 2019; 20: 1474–76—In this Comment, the cumulative incidence of recurrence in each group has been amended, owing to these data being corrected in the linked Article by Bertelsen and colleagues. […]

No Image

[Correspondence] Ivosidenib for advanced IDH1-mutant cholangiocarcinoma

August 1, 2020 0

Summary: We read with interest the Article by Ghassan Abou-Alfa and colleagues1 about ivosidenib in IDH1-mutant chemotherapy-refractory cholangiocarcinoma. Ivosidenib significantly improved progression-free survival compared with placebo, and this finding will probably convince the US Food and Drug Administration to approve it becoming the second targeted therapy available for cholangiocarcinoma (after […]

No Image

[Corrections] Correction to Lancet Oncol 2020; 21: e338

August 1, 2020 0

Summary: Maida M. Screening of gastrointestinal cancers during COVID-19: a new emergency. Lancet Oncol 2020; 21: e338—In this Correspondence, the listing of author Marcello Maida’s name was incorrect. This correction has been made as of Aug 3, 2020. Source: The Lancet Oncology Read More

No Image

[Clinical Picture] Skull base lymphoma with panhypopituitarism

August 1, 2020 0

Summary: In August, 2018, a 70-year-old man became progressively fatigued, nauseated, and lethargic over a period of 3 weeks. His primary care physician found that his thyroid-stimulating hormone and free triiodothyronine were both low. A brain MRI revealed a homogenously enhancing 24 ×18 ×16 mm mass in the hypothalamus that extended bilaterally […]

No Image

[Corrections] Correction to Lancet Oncol 2020; 21: e317–29

August 1, 2020 0

Summary: Erker C, Tamrazi B, Poussaint TY, et al. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 2020; 21: e317–29—In table 1 of this Series paper, the precontrast and postcontrast categories have been corrected. This correction has been made […]

No Image

[Corrections] Correction to Lancet Oncol 2020; 21: e330–36

August 1, 2020 0

Summary: Cooney TM, Cohen JK, Guimaraes CV, et al. Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 2020; 21: e330–36—In this Series paper, Fatema Malbari’s affiliation has been corrected. In table 1, the brain and gadolinium contrast administration […]

No Image

[Corrections] Correction to Lancet Oncol 2019; 20: e658

August 1, 2020 0

Summary: Dossa F, Wood T, Baxter NN. The incomplete story of complete mesocolic excision. Lancet Oncol 2019; 20: e658—In this Correspondence, the absolute reduction in risk of recurrence has been amended, owing to this being corrected in the linked Article by Bertelsen and colleagues. This correction has been made to […]